Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BLUEGENICS

Financiado

Cerrado

BlueGenics From gene to bioactive product Exploiting marine genomics for an i...

BlueGenics From gene to bioactive product Exploiting marine genomics for an innovative and sustainable European blue biotechnology industry Marine organisms, in particular sponges and their associated microorganisms, are an inexhaustible source of novel bioactive (lead) compounds for biomedical application. Industrial exploitation of this natural resource using tradit... ver más

31/07/2016

UMC-Mainz

8M€

Presupuesto del proyecto: 8M€

Líder del proyecto

UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 13 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-07-31 No tenemos la información de la convocatoria

0% 74% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

13 Participantes

UMC-Mainz

0.00€ | Lider

UEA

N.D. | Participante

BIOTRENDINOVACAO E ENGENHARI...

N.D. | Participante

UNINA

N.D. | Participante

Proyectos interesantes

COMBO

Medical Technol...

Biotechnology

4M€ Cerrado

IDENTIFICACIÓN DE NUEVOS COMPUESTOS NATURALES...

Medical Technol...

Materials Scien...

673K€ Cerrado

IDENTIFICACIÓN DE NUEVOS COMPUESTOS NATURALES...

Medical Technol...

Materials Scien...

49K€ Cerrado

BlueBio4Future

Medical Technol...

Biotechnology

2M€ Cerrado

INC-TU-2011-1848

Medical Technol...

Nanotechnology

75K€ Cerrado

OCEANCHARCOT

Medical Technol...

Biotechnology

279K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 8M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Marine organisms, in particular sponges and their associated microorganisms, are an inexhaustible source of novel bioactive (lead) compounds for biomedical application. Industrial exploitation of this natural resource using traditional approaches is, however, hampered, with a few exceptions, by unsolvable supply problems - despite of numerous efforts in the past. Therefore, there is, very likely, only one way: to start from the genes encoding the bioproducts, or their biosynthetic pathways, to sustainably obtain the active molecules in sufficient amounts. The aim of the presented industry-driven integrating project is to combine the knowledge in marine genomics, chemogenetics and advanced chemistry to produce recombinantly prepared novel secondary metabolite (lead) compounds and analogous from them, as well as pharmacologically active peptides, and to bring them up to the pre-clinical, and hopefully also to the clinical studies. This ambitious approach is based on breakthrough discoveries and the results of previous successful EU projects of members of the applying consortium, including European leaders (or worldwide leaders) in marine (sponge) genomics, metagenomics (polyketide synthase clusters), combinatorial biosynthesis and marine natural product chemistry/structure elucidation. This multidisciplinary project, driven by high-tech genomics-based SMEs with dedicated interest in bringing marine-biotechnology-derived products to the market, will also involve the discovery and sustainable production of bioactive molecules from hitherto unexploited extreme environments, such as hydrothermal vents and deep-sea sources, and the expression/scale-up of unique enzymes/proteins of biomedical and biotechnological interest. The molecular-biology-based strategies developed in this project for a sustainable exploitation of aquatic molecular biodiversity will further strengthen the international position and effectiveness of European (SME-based) blue biotechnology industry.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores